14 7 月, 2025 – Asia Featured

SeaPRwire

BlockBits Launches a Futures Trading Service, Offering Traders a Wide Range of Advanced Tools

14 7 月, 2025

Dubai, UAE – July 14, 2025 – (SeaPRwire) – BlockBits, crypto futures trading platform, launch a new tool for advanced futures trading for higher potential returns with up to 200x leverage. As cryptocurrency markets mature and price swings become more extreme, active traders are increasingly turning to risk management strategies once reserved for traditional finance. One strategy gaining notable traction is hedging – protecting open positions by opening an opposing trade to balance potential losses. Unlike in stocks or commodities, hedging in crypto has only recently become practical for a wider range of traders. With the expansion of futures and perpetual contracts, traders can now offset price movements without selling or transferring their core holdings – a key advantage for long-term investors facing short-term market uncertainty. “For example, a trader holding a major crypto asset can hedge against sudden volatility by opening a short futures position. If the asset’s price drops, gains from the short can help offset losses on the original holding – providing greater peace of mind in unpredictable conditions”, – said in company. Recognizing this growing need, several crypto exchanges are now integrating built-in hedging tools. Features such as the ability to hold both long and short positions on the same pair within a single account are making once-complex strategies more accessible. This is especially important for traders using high leverage or delta-neutral approaches, where profits and losses on opposite positions can balance each other out. Such tools also reduce trading costs by avoiding the need to close and reopen positions repeatedly – a process that can rack up fees and slippage in fast-moving markets. A smoother, single-interface experience means traders can react faster to market shifts without interrupting their broader investment plans. One platform at the forefront of this trend is BlockBits, which has designed its trading environment specifically with hedging in mind. Users can open long and short positions simultaneously on the same pair, track risk and margin separately, and monitor real-time profit/loss and liquidation levels across both sides. In a recent example with the ETH/USDT pair, BlockBits traders were able to hold dual up to 200× leverage positions – a feature not always offered by other exchanges. By integrating hedging into the core trading interface, platforms like BlockBits are helping crypto derivatives mature – providing tools that cater to both aggressive trading and robust risk management. As more traders seek to balance exposure without sacrificing opportunity, such innovations are set to become a standard part of the crypto futures landscape. Contact information Brand: BlockBits Contact: Media team E-mail: info@blockbitstech.com Website: https://blockbitstech.com/en

ACN Newswire

Buy International Homes at the Global Property Expo, Singapore

14 7 月, 2025

SINGAPORE, July 14, 2025 - (ACN Newswire via SeaPRwire.com) - For Singaporeans envisioning buying a residential property abroad, the Global Property Expo organised by JLL (NYSE: JLL) offers an unparalleled opportunity to embark on that journey. This premier exhibition, dedicated to international real estate investment, will open its doors from Friday, July 18, to Sunday, July 20, 2025, from 10:00 AM to 8:00 PM daily at B2, Sands Expo & Convention Centre. Attendance at the Expo is free of charge. Filled with talks and over 30 exhibitors, numerous expert and specialist advisors, the Global Property Expo is an indispensable platform for anyone considering a residential property purchase beyond Singapore's shores.Why Attend? Your Global Residential Property Search Starts Here.The Global Property Expo is meticulously curated to provide Singaporean buyers with all the tools and insights needed to navigate the complexities of overseas residential property ownership.See Properties from Across the World on the Exhibition Floor (30+ Exhibitors)As the most expansive international residential property show ever held in Singapore, potential buyers can discover a wide array of international residential properties and related services, representing a truly global showcase with offerings from more than 20 countries.Properties on exhibit span Bali to Bangkok, Lisbon to London, Dubai to Abu Dhabi, Perth to Auckland, Tokyo to Boston, and far beyond. Among the highlights, DAMAC Properties will showcase a curated selection of its signature waterfront developments, including Canal Crown, Altitude, Canal Heights, Canal Heights II, Couture by Cavalli, DAMAC Bay, DAMAC Bay 2, and DAMAC Casa.ThirdHome will officially launch its presence in Asia at the Global Property Expo, bringing to the fore property ownership possibilities all over the world with a new investment model. 3 Days of Learning Opportunities The Global Property Expo features talks on stage in the centre of the Exhibition from 11:00 AM to 6:30 PM daily. The Opening Ceremony at 11:00 AM on Friday, 18 July 2025 features a keynote address delivered by Adam Challis, who leads UK Research & Strategy at JLL, offering invaluable market foresight.Learn how technology is democratising property ownership with tokenised buying, membership models, and more. And, don’t miss the Live-Streamed Closing Panel: "Buyers’ Toolkit: Your Next Steps to Owning Property Abroad" on Sunday at 6:00 PM. This live-streamed panel will distil the most actionable advice from across the conference into a practical checklist for prospective buyers, from due diligence and financing to legal considerations and post-purchase management.Specialist Expertise On-SiteAttendees can engage directly with a comprehensive array of professionals. Developers will showcase their projects, while legal advisors will clarify international property laws, and mortgage advisors will guide you through financing options. Furthermore, property ownership can be a passport to residency. Immigration specialists will be on hand to discuss residency considerations linked to property purchase. This unparalleled access to experts ensures all your questions are answered under one roof.The Global Property Expo is an essential event for any Singaporean contemplating a residential property investment overseas, providing a comprehensive platform for education, expert advice, and direct access to a world of real estate opportunities.Register now at www.globalpropertyexpo.comAbout JLLFor over 200 years, JLL (NYSE: JLL), a leading global commercial real estate and investment management company, has helped clients buy, build, occupy, manage and invest in a variety of commercial, industrial, hotel, residential and retail properties. A Fortune 500 company with annual revenue of $23.4 billion and operations in over 80 countries around the world, our more than 112,000 employees bring the power of a global platform combined with local expertise. Driven by our purpose to shape the future of real estate for a better world, we help our clients, people and communities SEE A BRIGHTER WAYSM. JLL is the brand name, and a registered trademark, of Jones Lang LaSalle Incorporated. For further information, visit jll.com.Strategic Partner: About Leading Real Estate Companies of the World®Chicago-based Leading Real Estate Companies of the World® (LeadingRE.com) is a global network of top independent real estate firms, with 550 companies and 134,000 sales associates in over 70 countries. LeadingRE supports its members with powerful connections to other market leaders and access to innovative, performance-driven programs. Its online learning platform, LeadingRE Institute, was named to Training magazine’s Top 10 Hall of Fame. LeadingRE also operates RELO Direct®, Inc. (RELODirect.com), its full-service relocation management company providing mobility services for corporate and government clients; and Luxury Portfolio International® (LuxuryPortfolio.com), its luxury marketing division, which markets approximately 50,000 luxury homes annually. LeadingRE is also active in commercial real estate, with 200 firms in over 20 countries specializing in the commercial arena. The firm also has a strategic international project marketing program, Destinations by LeadingRE (DestinationsByLeadingRE.com).Notes to editors:Pre-event interviews with organisers and key stakeholders are available. Please contact Theodore below.Media are welcome to attend the Global Property Expo and may register at pressroom.globalpropertyexpo.com/accreditation.Please see the Appendix below for a full list of confirmed exhibitors and key topics.Stay up to date: sign up for email notifications at marketing@globalpropertyexpo.com. Follow Global Property Expo on Facebook, Instagram, or LinkedIn.Media Contact:media@globalpropertyexpo.com Theodore Woon, Director, PINPOINT PRWhatsApp/Telegram: +65 9155 3507 Email: theodore@pinpointpr.sgAppendixConfirmed exhibitors include leading names such as JLL, Barfoot & Thompson, British Land, DAMAC Properties Co. LLC, Destinations by LeadingRE, Devato, Chalegrove Properties Limited, Citrus Living, Crimson Education, EMAAR, ES-CON Japan Ltd, Far East Consortium, Finbar Group, GetGround, Gurner Group, Helios & America Mortgages, Hotel 101, HSBC, International Property Alerts, Leading Real Estate Companies in the World, Levella Global, Marjan, Mouana Luxury Villas Phuket, Richmind, The Boundary, ThirdHome, Tiger Brokers, Tropicana, UOB, and Vakson.The 3-day program is designed to demystify the process of buying abroad. Key topics include: Residential Investment 101: A Beginner’s Guide. How to choose the right agent and the pros and cons of renting versus owning; Current market trends and hotspots for buyers.Regional spotlights (Southeast Asia, Japan, Middle East, Australia-New Zealand, USA) with developers presenting their latest projects.Property technology innovations, including insights from Japanese VC MetaProp and local company PropNex.Alternative wealth-creation strategies: fractional ownership, tokenisation, and membership models. Hear from Samuel Lee of Fraxtor on 20 July at 12:00 PM, followed by a panel with experts from MetaProp and THIRDHOME, exploring how shared ownership and blockchain are reshaping luxury property access.Seasoned investor insights: Hear firsthand from experienced investors on critical aspects like "My First Property Abroad: What I Wish I Knew" and "How HNWIs Are Building Passive Income Across Borders," providing practical lessons from those who have successfully diversified their portfolios.Luxury Real Estate & Branded Properties: What premium means in practice.Eco, Sustainability, Purpose, and Impact Investment. Copyright 2025 ACN Newswire via SeaPRwire.com.

JCN Newswire

Fujitsu’s AI-powered supply chain solution selected as transformative example of applied-AI technology by World Economic Forum

14 7 月, 2025

KAWASAKI, Japan, July 14, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited today announced that one of its Fujitsu Uvance solutions that optimizes customers' global supply chains using specialized AI agents has been selected by the World Economic Forum's (WEF) AI Governance Alliance as one of 18 global advanced AI solutions that are transforming business. An independent, cross-industry group of AI leaders worldwide participated in selecting the solutions for the MINDS Programme from hundreds of applications. Applications were anonymized, and the final selection was based on cases that were implemented in actual settings and that have already achieved concrete results. The MINDS Programme (Meaningful, Intelligent, Novel, Deployable Solutions) was launched by WEF to spotlight AI applications already delivering real impact across critical sectors like healthcare, energy and financial services.Developed on the "Fujitsu Data Intelligence PaaS (1)" all-in-one operation platform offered under the Fujitsu Uvance business model to solve societal issue, the solution transforms inventory management and ordering operations in the supply chain and supports advanced management decision-making. The "Fujitsu Kozuchi AutoML" AI service, which can rapidly generate high-precision machine learning models, creates dozens of demand forecasting models in minutes from data automatically gathered and ordered using a knowledge graph. The solution employs multiple AI agents specialized for tasks such as procurement, inventory, production, and sales. Based on real-time alerts for inventory shortages or excess inventory, each AI agent develops countermeasures such as changing suppliers or allocating inventory. From the proposed countermeasures, the orchestrator agent selects the best option considering the balance of cost, lead time, and risk, and the evaluator agent assesses its validity, enabling users to quickly take optimal action based on proposals made by AI.A simulation carried out using data from an imagined major company with approximately US$10 billion in annual sales, showed the solution reducing annual inventory management costs by approximately US$15 million and cutting unnecessary inventory stock by approximately US$20 million, in addition to reducing work hours by more than 50%. The solution was also able to carry out an operating profit impact assessment following a simulated natural disaster within 3 hours of its occurrence. Fujitsu provides this solution to manufacturing customers facing inventory management challenges, supporting supply chain efficiency and resilience enhancement. Moving forward, Fujitsu will continue to assist its customers in making optimal decisions to swiftly respond to unforeseen events such as geopolitical risks, natural disasters, and market fluctuations. Under Fujitsu Uvance, Fujitsu will leverage Decision Intelligence utilizing data and AI to strengthen sustainability in the face of supply chain uncertainty, advancing both corporate value creation and social contribution.(1) Fujitsu Data Intelligence PaaS : Fujitsu's platform service that securely integrates and stores structured and unstructured data dispersed inside and outside the enterprise, and builds a high-speed data analysis infrastructure while ensuring governance. By combining advanced AI technology, it is possible to quickly analyze integrated and stored data and derive information necessary for decision-making in real time.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsu.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2025 JCN Newswire via SeaPRwire.com.

JCN Newswire

“URECE” (Dotinurad) Launched in China as a treatment for Gout

14 7 月, 2025

TOKYO, July 14, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has launched “URECE®” (brand name in China: “Youlesi®”, generic name: dotinurad) in China as a treatment for Gout. URECE was approved by the National Medical Products Administration in China as a treatment for gout patients with hyperuricemia in December 2024.URECE is a new therapeutic medicine for gout and hyperuricemia discovered by FUJI YAKUHIN. It suppresses uric acid reabsorption and lowers blood uric acid levels by selectively inhibiting the urate transporter (URAT1) related to reabsorption of uric acid in the kidney.Eisai concluded a license agreement with FUJI YAKUHIN for China and five ASEAN member states: Indonesia, Malaysia, Myanmar, the Philippines, and Thailand, granting exclusive development and distribution rights in these countries. This approval in China is based on the results of a multicenter, active controlled, double-blind, parallel-group, randomized, Phase 3 study of 451 gout patients conducted in China by Eisai.1 The results of this study showed that the proportion of subjects with serum uric acid levels of 6.0mg/dL or less at 24 weeks, which was the primary endpoint, was 73.6% [95% confidence interval (CI): 67.8,79.5] in the dotinurad group and 38.1% [95% CI: 31.6, 44.5] in the comparator febuxostat group, confirming the statistical superiority of dotinurad 4 mg over febuxostat 40 mg (difference of proportion 35.87% [95%CI: 27.36, 44.37, p less than 0.001]) (see section 3. About the Phase 3 Clinical Trial”). Eisai has obtained approval for dotinurad in China, Thailand and the Philippines.Gout can develop at any age, is more common in men than women, and during an acute attack, can cause severe joint pain, swelling, redness, and inflammation. The pain gradually improves over a few days, but can sometimes last for weeks. If left untreated, the joint tissue may become damaged and deformed, leading to restrictions in daily activities and a decrease in quality of life.2The prevalence of gout is increasing, and it is estimated that there are currently about 23 million patients with gout in China.3 It is expected that the number of patients will further increase in the near future due tochanges in lifestyle and dietary preferences in accordance with socioeconomic development. Eisai is committed to providing URECE to more patients with gout in China as a new treatment option, and will contribute to improving the quality of life (QOL) of patients.“Youlesi®”Product OutlineChinese Trade name: “Youlesi” (URECE)Chinese generic name: Duo ti nuo lei pian (Dotinurad Tablets)Indication for use: It is indicated for gout patients with hyperuricemia.Dosage and administration: For oral use, the usual adult initial dosage is 1 mg of dotinurad once daily. The dose level should then be gradually increased as needed by checking blood uric acid levels. The usual maintenance dosage is 2mg once daily and may be adjusted according to the patient’s condition, but up to 4 mg once dailyAbout “URECE®” (Dotinurad)URECE is a therapeutic medicine for gout and hyperuricemia discovered by FUJI YAKUHIN. URECE selectively inhibits URAT1, one of the uric acid transporters, thus preventing reabsorption of uric acid by the kidneys and promoting uric acid excretion in the urine. In addition, URECE has a small effect on other transporters affecting uric acid secretion, so it reduces serum uric acid levels at lower doses. URECE is expected to have a low risk of side effects and drug interactions. In Japan, FUJI YAKUHIN obtained manufacturing and marketing approval for URECE in January 2020 and launched it in May 2020.Eisai concluded a license agreement with FUJI YAKUHIN for China and five ASEAN member states: Indonesia, Malaysia, Myanmar, the Philippines, and Thailand, granting exclusive development and distribution rights in these countries. URECE was approved in Thailand for gout and hyperuricemia in Thailand in September, 2024 and in the Philippines in February, 2025.About the Phase 3 Clinical Trial (Study FYU-981-J086-301)1This was a multicenter, active-controlled, double-blind, parallel-group, randomized, Phase 3 study conducted to confirm the superiority of dotinurad 4 mg over febuxostat 40 mg as the primary endpoint, assess safety, and confirm the noninferiority of dotinurad 2 mg to febuxostat 40 mg as the secondary endpoint in Chinese patients with gout. Patients with gout and serum uric acid (SUA) levels exceeding 7.0 mg/dL were randomly assigned to either the dotinurad group or the febuxostat group in a 1:1 ratio, investigational product treatment for 24 weeks (the dotinurad group received 1 mg/day for 4 weeks, 2 mg/day for 8 weeks, and 4 mg/day for 12 weeks, while the febuxostat group received 20 mg/day for 4 weeks and 40 mg/day for 20 weeks). The primary endpoint was the proportion of patients with SUA less than or equal to 6.0 mg/dL at 24 weeks, and the secondary endpoint was the proportion of patients with SUA less than or equal to 6.0 mg/dL at 12 weeks.Of the total 451 patients, 225 were assigned to the dotinurad group and 226 to the febuxostat group. Of these, 441 patients (220 in the dotinurad group and 221 in the febuxostat group) were included in the Full Analysis Set (FAS). For the primary endpoint, the proportion of patients with SUA less than or equal to 6.0 mg/dL at 24 weeks was 73.6% [95% confidence interval (CI): 67.8, 79.5] in the dotinurad group and 38.1% [95% CI: 31.6, 44.5] in the febuxostat group, confirming the statistical superiority of dotinurad 4 mg over febuxostat 40 mg (difference of proportion 35.87% [95% CI: 27.36, 44.37, p less than 0.001]).For the secondary endpoint, the proportion of patients with SUA less than or equal to 6.0 mg/dL at 12 weeks was 55.5% in the dotinurad group and 50.5% in the febuxostat group, confirming the statistical non-inferiority of dotinurad 2 mg to febuxostat 40mg (difference of proportion 5.24% [95% CI: -3.69, 14.17]).The most common adverse events were gouty arthritis, COVID-19, and liver function abnormality in the dotinurad group, and gouty arthritis, COVID-19, and increased alanine aminotransferase (ALT) in the febuxostat group. No new safety concerns with dotinurad were observed.References1. Sun J, Wang Y, Zhang X, et al. POS0255 A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDYCOMPARING EFFICACY OF DOTINURAD AND FEBUXOSTAT FOR THE TREATMENT OF GOUT IN CHINESESUBJECTS. Annals of the Rheumatic Diseases 2024;83:407-408.2. Huang, J., Ma, Z.F., Tian, Y. et al. Epidemiology and Prevalence of Gout in Mainland China: an Updated Systematic Review and Meta-Analysis. SN Compr. Clin. Med. 2, 1593–1606 (2020).3. Estimated data calculated from reference 2 and United Nations World Population Estimates - World Population Prospects, URL: https://population.un.org/wpp/Media Inquiries:Eisai Co., Ltd.Public Relations DepartmentTEL: +81-(0)3-3817-5120 Copyright 2025 JCN Newswire via SeaPRwire.com.

罗西·奥唐奈回应特朗普威胁要撤销其美国公民身份，并将爱泼斯坦事件带入争端 “`

13 7 月, 2025

(SeaPRwire) - 喜剧演员兼演员罗西·奥唐奈（Rosie O’Donnell）已回应唐纳德·特朗普（Donald Trump）威胁要撤销她美国公民身份的言论，这是这两位出生于纽约的前电视明星多年恩怨的最新进展。在特朗普发出威胁数小时后，奥唐奈在她的社交媒体上发布了一张美国总统与被定罪的性犯罪者杰弗里·爱泼斯坦（Jeffrey Epstein）的照片。特朗普几十年前曾与爱泼斯坦交往，现在正卷入一场激烈的公共讨论中，人们要求其政府公布完整的爱泼斯坦文件，而他在竞选期间似乎倾向于这样做。奥唐奈为这张具有指向性的图片配文道，她目前居住在爱尔兰，并正通过其祖父母的血统寻求爱尔兰公民身份。她写道：“我就是你所害怕的一切。一个大嗓门的女人，一个酷儿女性，一个说真话的母亲，一个在你将美国点燃之前就离开美国的美国人。你是美国所有错误的总和——而我则是你所憎恨的、美国仅存的正确。” 奥唐奈总结道：“你想撤销我的公民身份？那就尽管试试吧，橘色喷雾晒黑的‘乔佛里国王’（King Joffrey）。”她指的是HBO热门剧集《权力的游戏》（Game of Thrones）中邪恶的儿童国王。奥唐奈在爱尔兰RTÉ Radio 1的节目中露面时，进一步发表了评论。她说道：“我只是花五分钟随手写了个小帖子回应，没想到在网上引起了广泛关注。”她重申了自己对特朗普威胁的回应。“我非常自豪能够反对他所说、所做和所代表的一切。” 周六，特朗普在Truth Social上表示，他正在“认真考虑”剥夺奥唐奈的公民身份，声称她“不符合”美国的“最佳利益”。这位美国总统说：“她是对人类的威胁，应该留在爱尔兰这个美好的国家，如果他们想要她的话。” 特朗普的威胁是在其政府继续试图废除出生公民权法之际发出的。周四，一名联邦法官对特朗普终止出生公民权的命令下达了临时禁令。专家们认为，这意味着美国政府无权根据第十四修正案撤销在美国本土出生的公民的公民身份。就在最近，特朗普还威胁要撤销他昔日的盟友、现任主要批评者埃隆·马斯克（Elon Musk）（出生于南非）以及民主党纽约市市长候选人佐兰·马姆达尼（Zohran Mamdani）（出生于乌干达）的美国公民身份。然而，他对奥唐奈的威胁尤其带有情绪，因为两人有着多年的紧张关系。 2006年，奥唐奈在圆桌脱口秀节目《观点》（The View）的一期节目中对特朗普进行了显著批评，她曾是该节目的长期小组成员。奥唐奈就他出席的“美国小姐”（Miss USA）选美比赛（当时他共同拥有）新闻发布会发表了评论。与此同时，特朗普在《学徒》（The Apprentice）的一期节目中，在一次董事会会议上大发雷霆，期间他多次侮辱她。在2016年总统竞选期间，特朗普提起了这位喜剧演员。在与对手希拉里·克林顿（Hillary Clinton）的一次辩论中，他表示：“罗西·奥唐奈——我对她说过非常严厉的话，我想每个人都会同意她罪有应得，没有人会同情她。” 奥唐奈当时反击道，在一个帖子中称特朗普“永远不会成为总统”，在另一个帖子中则称他为“橘色混蛋”。与此同时，奥唐奈选择发布特朗普和爱泼斯坦的图片正值一个有趣的时刻。周六晚上，特朗普抨击了总检察长帕姆·邦迪（Pam Bondi），后者因未能完整公布爱泼斯坦文件而受到抨击。长期以来，一直有人呼吁查看一份据称属于爱泼斯坦的“客户名单”。（邦迪此前公布的一些文件几乎没有提供公众之前不知道的新信息）。“我的‘小伙子们’，在某些情况下，还有‘姑娘们’，怎么回事？他们都在攻击总检察长帕姆·邦迪，她干得非常棒！我们是一支团队，MAGA，我不喜欢现在发生的事情。我们有一个完美的政府，全世界都在谈论它，而‘自私的人’却试图破坏它，都是为了一个从未死去的人——杰弗里·爱泼斯坦。多年来，总是爱泼斯坦，没完没了。”特朗普说，鼓励人们不要再纠缠这个话题。 “一年前，我们的国家一片死寂，现在它是世界上最热门的国家。让我们保持这种状态，不要在杰弗里·爱泼斯坦这种没人关心的人身上浪费时间和精力。” 特朗普发表此番言论之际，正值一份报告的发布引发了强烈反弹，该报告的作者对爱泼斯坦案进行了审查。根据报告，他们的调查结果显示，没有证据表明爱泼斯坦保留了“客户名单”或被谋杀。报告还指出，“没有发现可信证据表明爱泼斯坦勒索过知名人士作为其行为的一部分。” 特朗普关于爱泼斯坦的评论一直备受关注，尤其是在6月初有人指控特朗普被列在与已故金融家兼被指控的性贩卖者爱泼斯坦相关的文件中之后。“这才是这些文件未被公开的真正原因。”他没有提供与此相关的证据。特朗普与爱泼斯坦的关系可以追溯到几十年前。在2002年的一次采访中，他说爱泼斯坦“非常有趣”。特朗普告诉记者：“甚至有人说，他和我一样喜欢美女，而且其中许多都比较年轻。” 2019年7月，NBC News的TODAY发布了一段据信是1992年的视频，显示特朗普在他的海湖庄园（Mar-a-Lago）接待爱泼斯坦。 2019年爱泼斯坦因联邦性贩卖指控被捕后，特朗普曾试图与他划清界限。 2019年，在椭圆形办公室讲话时，特朗普说：“我跟他[爱泼斯坦]闹翻了。我已经15年没和他说过话了。我不是他的粉丝，我可以告诉你。”本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

Love Island USA标志着有毒粉丝文化的新时代

13 7 月, 2025

(SeaPRwire) -本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。“Taylor Crumpton写道，当Islanders离开别墅，他们15分钟的成名时间结束后，他们常常会终生面临网络上的仇恨和谩骂。”

Finance

投资者注意：Pomerantz Law Firm 提醒在 Krispy Kreme, Inc. 投资中遭受损失的投资者注意集体诉讼以及即将到来的截止日期 – DNUT

13 7 月, 2025

(SeaPRwire) - 纽约, 2025年7月12日 — Pomerantz LLP宣布已对Krispy Kreme, Inc.（“Krispy Kreme”或“公司”）(NASDAQ: DNUT)提起集体诉讼。建议这些投资者通过或 646-581-9980, (或 888.4-POMLAW), 免费电话Ext. 7980联系Danielle Peyton。鼓励通过电子邮件咨询的人士提供他们的邮寄地址、电话号码和购买的股票数量。该集体诉讼涉及Krispy Kreme及其某些高管和/或董事是否从事了证券欺诈或其他非法商业行为。如果您在集体诉讼期间购买或以其他方式获得了Krispy Kreme的证券，您需要在2025年7月15日之前要求法院指定您为首席原告。可以在获取投诉副本。在2025年5月8日，开盘前，Krispy Kreme发布了其2025年第一季度的财务业绩，报告称其“净收入为3.752亿美元...下降了15.3%”和“净亏损为3340万美元，而去年同期的净亏损为670万美元。”此外，该公司宣布，由于“ McDonald’s部署时间表的不确定性”，它正在“重新评估[其]部署时间表以及与McDonald’s的合作”，并且“撤回[其]先前的全年展望，并且不更新”。受此消息影响，Krispy Kreme的股价下跌1.07美元，或24.71%，于2025年5月8日收于每股3.26美元。 Pomerantz LLP在纽约、芝加哥、洛杉矶、伦敦、巴黎和特拉维夫设有办事处，被公认为公司、证券和反垄断集体诉讼领域的一流公司之一。Pomerantz由已故的Abraham L. Pomerantz创立，他被称为集体诉讼律师界的院长，Pomerantz开创了证券集体诉讼领域。今天，85多年后，Pomerantz继续秉承他所建立的传统，为证券欺诈、违反信托义务和公司不当行为的受害者争取权利。该律师事务所已代表集体成员追回了无数数百万美元的损害赔偿金。请访问。律师广告。先前的结果并不保证类似的结果。联系方式：Danielle PeytonPomerantz LLP646-581-9980 ext. 7980 来源： Pomerantz LLP本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```

Finance

市场洞察与盈利预览

13 7 月, 2025

(SeaPRwire) - 本周，金融市场将准备对行业巨头的系列关键盈利报告做出反应。预计这些报告将提供对经济健康状况和股票市场走向的关键见解。其中最受关注的将是主要金融机构的盈利报告，这可能会为市场的其余部分定下基调。特别是，焦点将集中在银行业，因为JPMorgan Chase (NYSE:JPM) 和Citigroup (NYSE:C)发布其财务业绩。投资者渴望了解这些机构如何应对近期的经济挑战，尤其是在利率波动和通胀担忧的背景下。此外，科技行业也将受到密切关注，预计Netflix (NASDAQ:NFLX) 将公布其季度收益。分析师对这家流媒体巨头的用户增长和收入表现感到好奇，尤其是在几家竞争对手进入市场之后。零售销售数据也将发布，提供消费者支出行为的快照。经济学家将分析这些数据，以衡量在商品和服务成本上涨的情况下，消费者需求的强度。此外，消费者价格指数 (CPI) 报告将于本周发布，提供关于经济中通胀压力的进一步证据。高于预期的 CPI 可能会导致投资者调整他们对美联储未来加息的预期。总的来说，本周充满了可能显着影响市场情绪和投资策略的数据和盈利报告。投资者需要仔细解读这些信号，才能对他们的投资组合做出明智的决定。 Footnotes: 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。本周的市场预测包括各种经济报告和盈利发布。. ```